Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
Part of paid clinical trials in Houston, Texas.
- Sponsor
- National Center for Research Resources (NCRR)
- Study ID
- NCT00006131
- Status
- Completed
Conditions
- Herpes Zoster
- Immunologic Deficiency Syndromes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Valacyclovir — DRUG
Study Details
OBJECTIVES: I. Compare the efficacy and safety of two doses of oral valacyclovir in immunocompromised patients with uncomplicated herpes zoster. II. Compare quality of life, pain, and medical resource utilization in patients treated with these 2 regimens.
Key Dates
- Start date
- Jan 31, 1997
- Status verified
- Dec 2003
Study Design
- Enrollment
- 66 participants (estimated)
- Allocation
- RANDOMIZED
- Primary purpose
- TREATMENT
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center for Clinical Studies | Houston | Texas | 77058 | - |
Find similar trials in Houston, TX
By research site
Related Studies
- Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control PopulationPHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland